News for Nuvation Bio Inc. (NUVB-WT)

We recently compiled a list of the 12 Best NYSE Penny Stocks to Buy According to Analysts. In this article, we are going to take a look at where Nuvation Bio Inc.

Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D.

PR NewswireNEW YORK, Feb. 18, 2025 NEW YORK, Feb. 18, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether cer

Transaction Overview On December 31, 2024, FMR LLC (Trades, Portfolio) made a significant move by acquiring an additional 16,046,701 shares of Nuvation Bio Inc

Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced it has initiated an E

Nuvation Bio Inc. (NYSE: NUVB), a global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced that David Hung, M.D.

PR NewswireSAN FRANCISCO and SUZHOU, China, Jan. 2, 2025 SAN FRANCISCO and SUZHOU, China, Jan. 2, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent"

Nuvation Bio Inc. (NUVB), Monday announced that the U.S. Food and Drug Administration has granted Priority Review for the company's New Drug Application for Taletrectinib and assigned a Prescription Drug User Fee Act date on June 23.

FDA sets review date for Nuvation Bio's cancer drug

SAN FRANCISCO and SUZHOU, China, Dec. 20, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ('Innovent') (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, today announced that China's National Medical Products Administration (NMPA) has approved a New Drug Application (NDA) of DOVBLERON ® (taletrectinib adipate capsule), a next-generation ROS1 tyrosine kinase inhibitor (TKI), for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC) who have been previously treated with ROS1 TKIs. DOVBLERON® marks the 13th addition to Innovent's commercial portfolio, representing an innovative precision therapy expected to benefit more lung cancer patients alongside our strong TKI franchise.

Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced

As of Nov. 11, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading d...

We recently published a list of 11 Best NYSE Penny Stocks to Buy Right Now. In this article, we are going to take a look at where Nuvation Bio Inc.

Insider Activity Roundup: Thursday's Top Buys and Sells in US Stocks

Israel-based Silexion Therapeutics Corp (SLXN), a biopharmaceutical company is up over 44 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Shares of Oracle Corporation ORCL rose sharply in today's pre-market trading after the company reported better-than-expected earnings and sales results for its ...

Loading... Loading... The Dow Jones index closed lower by around 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or...

Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fourth-quarter revenue outlook below estimates.

Shares of Westport Fuel Systems Inc. (NASDAQ: WPRT) fell sharply during Tuesday’s session after posting a wider-than-expected fourth-quarter loss. Westport Fuel Systems posted a quarter loss of 81 cents per share, compared to market expectations for a loss of 51 cents per share.